Gexcal Softgel Capsule is a combination pharmaceutical formulation containing Calcitriol (0.25 mcg), Calcium Carbonate (625 mg), and Vitamin K2-7 (45 mcg), designed to support bone health and calcium metabolism. Calcitriol, the active form of vitamin D3, plays a critical role in enhancing intestinal absorption of calcium and phosphate, thereby aiding in the maintenance of normal serum calcium levels and promoting bone mineralization. Calcium Carbonate serves as a vital mineral supplement, essential for the development and maintenance of strong bones and teeth, and is commonly used in the prevention and treatment of calcium deficiencies. Vitamin K2-7 (menaquinone-7) is included for its role in activating osteocalcin, a protein necessary for binding calcium to the bone matrix, thus contributing to improved bone density and reducing the risk of fractures. This combination is particularly beneficial in conditions such as osteoporosis, hypocalcemia, and other metabolic bone diseases where calcium and vitamin D metabolism is impaired. Gexcal Softgel Capsule should be administered under medical supervision, with dosage tailored according to individual patient needs and serum calcium levels, to avoid hypercalcemia and other potential adverse effects. Regular monitoring is recommended to ensure therapeutic efficacy and safety.